2020 has certainly been one for the ages and from an investment point of view the healthcare sector ... Read More
Mackie Research analyst André Uddin says investors can expect long-term organic growth and margin i... Read More
Mackie Research Capital analyst André Uddin ussued an update to clients Monday on Medexus Pharmaceu... Read More
Mackie Research analyst André Uddin is staying bullish on specialty pharma company Medexus Pharmace... Read More
Following the company’s fourth quarter results, Mackie Research Capital analyst André Uddin i... Read More
After being granted Health Canada approval to distribute Treosulfan, a conditioning agent used prior... Read More